Mark Jitlal
- Oncology top 5%
- Colorectal Cancer Surgical Treatments 4
-
- Lung Cancer Treatments and Mutations 4
- Gallbladder and Bile Duct Disorders 3
- Surgery top 5%
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
- Colorectal and Anal Carcinomas 6
- Ecological Modeling top 10%
- Health top 10%
- Health disparities and outcomes 3
-
- Multiple Myeloma Research and Treatments 4
-
- Dementia and Cognitive Impairment Research 3
- Co-authors
- Rob Glynne‐JonesDavid Sebag‐MontefioreEmily GrundyHelen MeadowsJohn BridgewaterJohn NorthoverHarpreet WasanR.D. James
- Journals
- Journal of Clinical Oncology (5 papers)British Journal of Cancer (3 papers)European Journal of Cancer (3 papers)
- Partner nations
- United KingdomCanadaJapan
In The Last Decade
Mark Jitlal
39 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 123
- Oncology 603
- Pulmonary and Respiratory Medicine 546
- Surgery 736
- Ecological Modeling 54
- Health 66
Countries citing papers authored by Mark Jitlal
This map shows the geographic impact of Mark Jitlal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Jitlal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Jitlal more than expected).
Fields of papers citing papers by Mark Jitlal
This network shows the impact of papers produced by Mark Jitlal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Jitlal. The network helps show where Mark Jitlal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Jitlal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2022 | 25 | |
| 3 | 2021 | 49 | |
| 4 | 2020 | 24 | |
| 5 | 2020 | 5 | |
| 6 | Vitamin D levels in the UK MS population and COVID-19 susceptibility | 2020 | 1 |
| 7 | 2020 | 2 | |
| 8 | 2019 | 19 | |
| 9 | 2015 | 26 | |
| 10 | 2015 | 25 | |
| 11 | 2015 | 21 | |
| 12 | 2014 | 38 | |
| 13 | 2013 | 267 | |
| 14 | 2012 | 59 | |
| 15 | 2012 | 31 | |
| 16 | 2010 | 93 | |
| 17 | 2010 | 40 | |
| 18 | 2009 | 95 | |
| 19 | 2009 | 50 | |
| 20 | 2007 | 79 |
About Mark Jitlal
Mark Jitlal is a scholar working on Oncology, Pharmacy, Hematology, Health and Surgery, having authored 39 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Colorectal and Anal Carcinomas (6 papers), Multiple Myeloma Research and Treatments (4 papers), Colorectal Cancer Surgical Treatments (4 papers), Lung Cancer Treatments and Mutations (4 papers), Dementia and Cognitive Impairment Research (3 papers), Health disparities and outcomes (3 papers) and Gallbladder and Bile Duct Disorders (3 papers). The work is most often cited by research in Oncology (603 citations), Pulmonary and Respiratory Medicine (546 citations), Surgery (736 citations), Ecological Modeling (54 citations) and Health (66 citations). Mark Jitlal has collaborated with scholars based in United Kingdom, Canada and Japan. Frequent co-authors include Rob Glynne‐Jones, David Sebag‐Montefiore, Emily Grundy, Helen Meadows, John Bridgewater, John Northover, Harpreet Wasan, R.D. James, Juan W. Valle and Sandy Beare. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, European Journal of Cancer, Annals of Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.